Cryopreserved Cord Blood Products Mitigate Fluorouracil Myelodepression in Mice
DOI:
https://doi.org/10.15407/cryo25.04.359Keywords:
cytotoxicants, fluorouracil, myelodepression, hemopoiesis, cord blood, cryopreserved nucleated cellsAbstract
Myelodepression is one of the major pathological syndromes resulting from cytotoxicant action on humans and animals. Effect of cryopreserved cord blood cell preparation (CB) on recovery dynamics of bone marrow hematopoiesis in CBA mice was studied with the model of cytostatic myelodepression caused by the use of 5-fluorouracil (5-FU) in maximum tolerated dose (228 mg/kg). It was shown that 5-FU introduction caused an expressed myelodepression and slowered reparation of hemopoietic tissue and its individual lineages. The most sensitive to 5-FU effect were cells of myeloid and erythroid lineages, and less sensitive appeared to be the lymphoid cells. Intravenous administration of CB preparation contributed to bone-marrow hematopoietic regeneration to the 12th day and complete reduction of toxic leukopenia to the 9th day of the experiment.
Probl Cryobiol Cryomed 2015; 25(4):359-370.
References
Babijchuk L.A., Kudokotseva O.V., Zubov P.M., Zubova O.L. New approaches to cryopreservation of cord blood nucleated cells and assessing their viability. Ukr Khimioterapevt J 2008; (1–2): 85–87.
Babijchuk L.A., Zubov P.M., Ryazantsev V.V, et al. Cord blood as alternative source of stem cells for regenerative medicine: new approaches to the problem of cryopreservation. Bukovinskiy Medychnyy Visnyk 2009; 13(4): 23–26.
Bonitenko Yu.Yu., Nikiforova A.M., editors. Emergencies of chemical nature: chemical incidents, mass poisoning, medical aspects. St. Petersburg: Gippocrat; 2004.
Borsuk O.S., Masnaya N.V., Churin A.A., Sherstoboev E.Y. Preclinical investigation of plant drugs under conditions of cytostatic influence. Biomedicine 2010; 1(2): 53–64.
Broxmeyer H.E., Douglas G.W., Hangos G. et al. Human umbilical cord blood as a potential source of transplantantable hematopoietic stem/progenitor sells. Proc Natl Acad Sci USA 1989; 86: 3828–3832. CrossRef PubMed
Cassileth B.R., Deng G. Complementary and alternative therapies for cancer. The Oncologist 2004; 9(1): 80–89. CrossRef
Czygier M., Dakowicz L., Szmitkowski M. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma. Adv Med Sci 2007; 52: 143–146. PubMed
Ende N., Weinstein F., Chen R., Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sei 2000; 67(1): 53–59. CrossRef
Goldberg E.D., Dygai A.M., Zhdanov V.V. Hemopoiesis-inducing microenvironment role in hematopoiesis regulation during cytostatic myelosuppression. Tomsk: STT; 1999.
Goldstein G., Toren A., Nagler A. Transplantation and other uses of human umbilical cord blood and stem cells. Curr Pharm Des 2007; 13(13): 1363–1373. CrossRef PubMed
Goltsev A.N., Kalinichenko T.A. Human umbilical cord blood as a source of hemopoietic cells for clinical application. Part I. Nature of hemopoietic potential. Problems of Cryobiology 1998; (1): 3–24.
Goltsev A.N., Kalinichenko T.A. Human umbilical cord blood as a source of hemopoietic cells for clinical application. Part II. Immunological characteristics. Problems of Cryobiology 1998; (1): 3–21.
Harris D.T. Non-haematological uses of cord blood stem cells. Br J Haematol 2009; 147(2): 177–184. CrossRef PubMed
Korsun V.F., Treskunov K.A., Korsun E.V. et al. Medicinal plants in oncology. Moskow: Prakticheskaya Meditsyna; 2007.
Kudokotseva O.V., Kovalenko I.F., Lomakin I.I., Babijchuk G.A. Correction of anemia resulting from 5–fluorouracil toxic effect using cryopreserved preparations of cord blood. Probl Cryobiol Cryomed 2014; 24(4): 312–321. CrossRef
Kudokotseva O.V. Lomakin I.I. Biological activity of cryopreserved cord blood cell preparations, depending on their derivation methods. In: Proceedings of the international interdisciplinary scientific conference 'Biologically active substances and materials: fundamental and applied issues of derivation and application' 2013; 2: p. 357–358.
Kudokotseva O.V. Lomakin I.I., Purysheva V.Yu. Correction of hematopoietic system disorders caused by experimental hypothyroidism with cryopreserved cord blood preparations. Ukr Khimioterapevt J 2012; 27(3): 64–68.
Lomakin I.I., Kudokotseva O.V. Correction of endocrine pathology of rats with aerocryotherapy cell preparations. In: Proceedings of international scientific and practical conference 'Priority directions of medical sciences development in modern reformation processes'; Dnepropetrovsk: Salutem; 2012. p. 16–20.
Matyash M.T. Features and action mechanisms of hemostimulating effect of preparations of different pharmacological groups in terms of anti-tumor chemotherapy [dissertation]. Tomsk; 2008.
Melikhova V.S., Isaev A. Cell populations isolated from umbilical and placental complex and prospects of their scientific and practical use. Cellular Transplantation and Tissue Engineering 2007; 2(4): 31–38.
Murohara T., Ikeda H., Duan J. et al. Transplanted cord blood–derived endothelial precursor cells augment postnatal neovas-cularization. J Clin Invest 2000; 105(11): 1527–1536. CrossRef PubMed
Musina R.A., Bekchanova E., Belayvski A. et al. Mesenchymal stem cells from umbilical cord blood. Cell Technologies in Biology and Medicine 2007; (1): 16–20.
Ogorodnikova E.V. Melkova K.N., Mkheidze D.M. Hemotransfusion support during high-dose chemotherapy with autologous hematopoietic stem cell transplantation. Russian Journal of Oncology 2003; (1): 56–65.
Perekhrestenko P.M., Anoshyna M.Y., Tretyak N.M. et al. Transfusion influence of hemopoietic of cord blood cells on lipid peroxidation in patients with cytostatic hemodepression. Ukr Journal of Hematology and Transfusiology 2006; 6(2): 25–30.
Podoltseva E.I. Colony-stimulating factors in oncology. Practical Oncology 2001; 5(1): 21–24.
Purysheva V.Yu, Volina V.V., Kudokotseva O.V., Babijchuk L.A. Effect of cord blood cell preparations on morphology of rat skin. Svit Meditsiny I Biologii 2009; 1(3): 131–136.
Rumyantsev A.G., Maschan A.A. Hematopoietic stem cell transplantation in children. Moscow: MIA; 2003.
Skil T., editor. Anticancer chemotherapy. Moscow: GEOTAR Med; 2011.
Smirnov V.S., Freydlin I.S. editors. Immunodeficiency states. St. Petersburg: Foliant; 2000.
Udut E.V. Correction of anemia with the myeloinhibiting effects [dissertation]. Tomsk; 2008.
Vladimirskaya E.B., Mayorova O.A., Rumyantseva S.A., Rumyantsev A.G. Biological grounds and prospects of stem cell therapy. Moscow: Medpraktika; 2005.
Zborovsky A.B., Tyurenkov I.N. Complications of pharmaco-therapy: Manual for physicians. Moscow: Meditsyna; 2003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Olga V. Kudokotseva, Ivan I. Lomakin, Georgiy A. Babijchuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
